Ed Ahearne combined automation , machine learning and Bayesian optimization to speed up method development for siRNA medicines. At ISC 2016, Edward Ahearne of AstraZeneca’s Pharmaceutical Sciences - ...
An unexpected shot of bad news. A popular weight-loss shot has been recalled across the country by the FDA due to potential ...
ASPEN links green sputum to neutrophils and exacerbations; brensocatib (DPP1) lowers purulence, while meta-analysis supports ...
Pharmaceutical major Dr. Reddy's Laboratories Limited has received a positive recommendation from the Subject Expert ...
Make Japanese-style rice at home even without a rice cooker. By following a simple heat schedule and keeping the lid closed ...
Netmums on MSN
Spraying vinegar, water, and dish soap on your shower screen: why this hack is recommended and what it really does
Hard-water showers across the UK leave glass screens streaked with stubborn limescale and soap scum. Cleaning experts now ...
Dr. Roach weighs in on whether a patient should proceed with a prostate biopsy after conflicting test results.
A doctor advises a 68-year-old patient with a high 4Kscore result to proceed with a prostate biopsy despite a low-risk MRI.
A reader's low-risk MRI and high-risk 4Kscore present a diagnostic challenge with no single validated tool to reconcile them.
I am 68 years old and have an enlarged prostate and benign prostatic hyperplasia (BPH). I’ve been taking tamsulosin for about ...
10h
Dear Doctor: There's a 49% chance of aggressive prostate cancer, but my doctor is hesitant to biopsy
A conflicting MRI result and the complications of blood thinner use have left one 68-year-old man and his physician at a crossroads.
A 68-year-old man with elevated PSA and a high 4Kscore faces a difficult decision between prostate biopsy and continued ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results